Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cns Pharmaceuticals Inc (CNSP)

Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,134
  • Shares Outstanding, K 33,446
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,850 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta 2.58
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.27
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -74.97
  • Most Recent Earnings $-0.25 on 11/14/24
  • Next Earnings Date 11/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +333,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1000 +35.60%
on 11/04/24
0.3699 -63.34%
on 10/23/24
-0.0104 (-7.12%)
since 10/21/24
3-Month
0.1000 +35.60%
on 11/04/24
0.3699 -63.34%
on 10/23/24
-0.0304 (-18.31%)
since 08/21/24
52-Week
0.0955 +41.99%
on 08/16/24
135.0000 -99.90%
on 11/22/23
-104.3644 (-99.87%)
since 11/21/23

Most Recent Stories

More News
CNS Pharmaceuticals (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual Meeting

CNS Pharmaceuticals (NASDAQ: CNSP) announced that its abstract on the pivotal trial of Berubicin, a novel treatment for glioblastoma multiforme (“GBM”), has been selected for poster presentation at...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) Advances Glioblastoma Treatment with Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP) reported Q3 2024 financial results and highlighted clinical advancements, including the ongoing potentially pivotal trial of Berubicin, a targeted chemotherapy for recurrent...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Berubicin’s Potential During KOL Connect Event

CNS Pharmaceuticals (NASDAQ: CNSP), focused on innovative cancer therapies for brain and central nervous system cancers, recently participated in a Virtual Investor KOL Connect segment featuring Professor...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) Secures $3 Million in Registered Direct Offering

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on developing treatments for cancers affecting the brain and central nervous system, has announced that it has entered into securities...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) Management Participates in Virtual Investor KOL Connect Segment

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Participation at Biotech in Europe Forum

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum

Webcast presentation on Wednesday, September 25th at 1:55 PM CEST

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted...

CNSP : 0.1350 (+9.22%)
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at Virtual Biotech Investment Webinar

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company...

CNSP : 0.1350 (+9.22%)

Business Summary

CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is...

See More

Key Turning Points

3rd Resistance Point 0.1646
2nd Resistance Point 0.1510
1st Resistance Point 0.1373
Last Price 0.1350
1st Support Level 0.1100
2nd Support Level 0.0964
3rd Support Level 0.0827

See More

52-Week High 135.0000
Fibonacci 61.8% 83.4665
Fibonacci 50% 67.5478
Fibonacci 38.2% 51.6290
Last Price 0.1350
52-Week Low 0.0955

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar